Status:

UNKNOWN

Impact of Nasoseptal Flap Harvest Technique on Olfaction Following Endoscopic Transsphenoidal Pituitary Surgery

Lead Sponsor:

Unity Health Toronto

Conditions:

Pituitary Tumor

Surgery

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Pituitary tumours have an estimated prevalence of 20% in the general population and the number of clinically relevant pituitary adenomas is increasing with time. When symptomatic, the standard of care...

Detailed Description

Pedicled nasoseptal flaps are used to repair skull base defects following endoscopic transphenoidal surgery. The superior incision is placed in close proximity to olfactory mucosa. Currently, these fl...

Eligibility Criteria

Inclusion

  • Adult patients (age ≥18 years)
  • Patients with tumours of the pituitary gland electively scheduled for endoscopic transsphenoidal surgery with nasoseptal flap coverage

Exclusion

  • Documented evidence of sinonasal disease on either nasal endoscopy or radiography
  • Patients with a clinical history of asthma and/or sinonasal disease
  • Previous sinus surgery
  • Previous skull base surgery
  • History of pre-existing hyposmia or anosmia
  • Use of medication(s) known to alter sense of smell at time of test
  • UPSIT scores \<5 indicating a functional component to alteration in olfaction
  • Development of postoperative cerebrospinal fluid leak necessitating re-entry into the operative field containing the nasoseptal flap

Key Trial Info

Start Date :

February 25 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2019

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT03773705

Start Date

February 25 2019

End Date

December 31 2019

Last Update

March 15 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

St. Michael's Hospital

Toronto, Ontario, Canada, M5B 1W8